We are proud to announce that Dr. Cong MA from ABCT has won the Global Innovation Award at the TechConnect 2019 with his innovation "New Antibiotic Drug Candidates".
The TechConnect World Innovation Conference and Expo 2019 was held on 17-19 June in Boston. It is an annual event for connecting top applied research and early-stage innovations from universities/ laboratories, and start-ups with industry end-users and prospectors to foster the commercialisation of innovations.
Over 600 submissions from global top tier universities and national laboratories such as Massachusetts Institute of Technology (MIT), Sandia National Laboratories, Argonne National Laboratory and EPFL-LPAC etc. were received this year, and the Innovation Awards go to the top 15% of submitted technologies.
The interdisciplinary research project "New Antibiotic Drug Candidates" by Dr. Cong MA and Dr. Xiao YANG (CUHK) makes use of computer-aided approaches in drug discovery, they discovered small molecules with high potential to be developed into novel antimicrobial agents fighting against the superbugs. Based on a new target, new chemical structure and new mechanism different from the existing antibiotics, these compounds demonstrated great effect of inhibiting bacterial growth, yet with no toxicity to human cells. They are now approaching the pre-clinical development stage. New antimicrobial resistance mechanisms are emerging and spreading globally, threatening human health. These novel drug candidates could potentially be strong complements to the current antibiotics for treating infectious diseases.
Let us take this opportunity to congraulate Dr. Cong MA on receiving the honour! For details, please visit https://www.polyu.edu.hk/web/en/media/media_releases/index_id_6656.html
The TechConnect World Innovation Conference and Expo 2019 was held on 17-19 June in Boston. It is an annual event for connecting top applied research and early-stage innovations from universities/ laboratories, and start-ups with industry end-users and prospectors to foster the commercialisation of innovations.
Over 600 submissions from global top tier universities and national laboratories such as Massachusetts Institute of Technology (MIT), Sandia National Laboratories, Argonne National Laboratory and EPFL-LPAC etc. were received this year, and the Innovation Awards go to the top 15% of submitted technologies.
The interdisciplinary research project "New Antibiotic Drug Candidates" by Dr. Cong MA and Dr. Xiao YANG (CUHK) makes use of computer-aided approaches in drug discovery, they discovered small molecules with high potential to be developed into novel antimicrobial agents fighting against the superbugs. Based on a new target, new chemical structure and new mechanism different from the existing antibiotics, these compounds demonstrated great effect of inhibiting bacterial growth, yet with no toxicity to human cells. They are now approaching the pre-clinical development stage. New antimicrobial resistance mechanisms are emerging and spreading globally, threatening human health. These novel drug candidates could potentially be strong complements to the current antibiotics for treating infectious diseases.
Let us take this opportunity to congraulate Dr. Cong MA on receiving the honour! For details, please visit https://www.polyu.edu.hk/web/en/media/media_releases/index_id_6656.html
